COL9A3

collagen type IX alpha 3 chain, the group of Collagen proteoglycans|Collagens

Basic information

Region (hg38): 20:62816244-62841159

Links

ENSG00000092758NCBI:1299OMIM:120270HGNC:2219Uniprot:Q14050AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • epiphyseal dysplasia, multiple, 3 (Moderate), mode of inheritance: AD
  • epiphyseal dysplasia, multiple, 3 (Definitive), mode of inheritance: AD
  • Stickler syndrome (Strong), mode of inheritance: AR
  • epiphyseal dysplasia, multiple, 3 (Moderate), mode of inheritance: AD
  • multiple epiphyseal dysplasia due to collagen 9 anomaly (Supportive), mode of inheritance: AD
  • autosomal recessive Stickler syndrome (Supportive), mode of inheritance: AR
  • Stickler syndrome (Limited), mode of inheritance: AR
  • stickler syndrome, IIa 6 (Definitive), mode of inheritance: AR
  • epiphyseal dysplasia, multiple, 3 (Strong), mode of inheritance: AD
  • stickler syndrome, IIa 6 (Strong), mode of inheritance: AR
  • Stickler syndrome (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Stickler syndrome, type VIARAudiologic/Otolaryngologic; OphthalmologicThough the condition may be recognizable, early recognition and treatment of hearing impairment may improve outcomes, including speech and language development; Avoidance of risk factors related to ocular manifestations (eg, contact sports) is indicatedAudiologic/Otolaryngologic; Craniofacial; Musculoskeletal; Ophthalmologic10090888; 10655510; 15551337; 20301302; 24273071; 30450842; 31090205; 33570243; 35241111

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the COL9A3 gene.

  • not provided (17 variants)
  • Stickler syndrome, IIa 6 (3 variants)
  • Epiphyseal dysplasia, multiple, 3 (1 variants)
  • Epiphyseal dysplasia, multiple, 3, with myopathy (1 variants)
  • Inborn genetic diseases (1 variants)
  • Stickler syndrome (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the COL9A3 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
6
clinvar
217
clinvar
9
clinvar
232
missense
480
clinvar
20
clinvar
9
clinvar
509
nonsense
8
clinvar
3
clinvar
3
clinvar
14
start loss
0
frameshift
8
clinvar
4
clinvar
7
clinvar
19
inframe indel
28
clinvar
1
clinvar
29
splice donor/acceptor (+/-2bp)
2
clinvar
3
clinvar
19
clinvar
24
splice region
2
52
64
2
120
non coding
9
clinvar
308
clinvar
91
clinvar
408
Total 18 10 552 546 109

Highest pathogenic variant AF is 0.0000198

Variants in COL9A3

This is a list of pathogenic ClinVar variants found in the COL9A3 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
20-62817046-G-T Likely benign (Mar 11, 2020)1183916
20-62817069-C-A Inborn genetic diseases Uncertain significance (Jul 06, 2021)2235240
20-62817069-C-T Uncertain significance (Aug 12, 2022)2429509
20-62817070-CG-C Pathogenic (Oct 04, 2022)2034095
20-62817071-G-C Uncertain significance (Jan 05, 2024)1921205
20-62817074-C-G Uncertain significance (Dec 11, 2020)1507726
20-62817075-C-T Uncertain significance (Jan 31, 2024)1314108
20-62817077-C-A Uncertain significance (Jun 14, 2022)1804296
20-62817077-C-T Uncertain significance (Jan 08, 2023)1315133
20-62817079-C-T Likely benign (Nov 19, 2023)2843948
20-62817081-C-T Uncertain significance (Jul 06, 2022)1058937
20-62817082-G-A Likely benign (Jun 16, 2023)3013729
20-62817082-G-T Likely benign (Nov 10, 2022)1576341
20-62817083-T-A COL9A3-related disorder Benign/Likely benign (Jan 05, 2024)426860
20-62817085-C-T Likely benign (Apr 26, 2023)1540539
20-62817086-G-A Uncertain significance (Mar 10, 2023)1915027
20-62817087-C-T Uncertain significance (Dec 31, 2022)2819384
20-62817089-C-T Inborn genetic diseases Uncertain significance (Nov 19, 2023)1464984
20-62817090-C-G Uncertain significance (Oct 26, 2022)1943211
20-62817090-C-T Uncertain significance (Mar 17, 2023)1224425
20-62817090-CGCTCCT-C Uncertain significance (Aug 23, 2022)1912695
20-62817091-G-T Likely benign (Apr 06, 2023)1980903
20-62817090-C-CGCTCCT COL9A3-related disorder Uncertain significance (Dec 19, 2023)1422320
20-62817090-C-CGCTCCTGCTCCT Uncertain significance (Jun 20, 2022)1486712
20-62817092-C-G Uncertain significance (Mar 20, 2023)2847848

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
COL9A3protein_codingprotein_codingENST00000343916 3224916
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
3.28e-120.9991256880601257480.000239
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.3824714481.050.00002934119
Missense in Polyphen186192.840.964541756
Synonymous-2.332311901.210.00001441544
Loss of Function3.002749.90.5410.00000303525

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0006100.000598
Ashkenazi Jewish0.0001000.0000992
East Asian0.0002730.000272
Finnish0.000.00
European (Non-Finnish)0.0002550.000246
Middle Eastern0.0002730.000272
South Asian0.0003620.000359
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Structural component of hyaline cartilage and vitreous of the eye.;
Disease
DISEASE: Multiple epiphyseal dysplasia 3 (EDM3) [MIM:600969]: A generalized skeletal dysplasia associated with significant morbidity. Joint pain, joint deformity, waddling gait, and short stature are the main clinical signs and symptoms. Radiological examination of the skeleton shows delayed, irregular mineralization of the epiphyseal ossification centers and of the centers of the carpal and tarsal bones. Multiple epiphyseal dysplasia is broadly categorized into the more severe Fairbank and the milder Ribbing types. The Fairbank type is characterized by shortness of stature, short and stubby fingers, small epiphyses in several joints, including the knee, ankle, hand, and hip. The Ribbing type is confined predominantly to the hip joints and is characterized by hands that are normal and stature that is normal or near-normal. {ECO:0000269|PubMed:10090888, ECO:0000269|PubMed:25381065}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Intervertebral disc disease (IDD) [MIM:603932]: A common musculo-skeletal disorder caused by degeneration of intervertebral disks of the lumbar spine. It results in low-back pain and unilateral leg pain. {ECO:0000269|PubMed:11308397, ECO:0000269|PubMed:25381065}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Susceptibility to intervertebral disk disease is conferred by variant p.Arg103Trp (PubMed:11308397). {ECO:0000269|PubMed:11308397}.;
Pathway
PI3K-Akt signaling pathway - Homo sapiens (human);ECM-receptor interaction - Homo sapiens (human);Focal adhesion - Homo sapiens (human);Protein digestion and absorption - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);Gastric Cancer Network 2;PI3K-Akt Signaling Pathway;Developmental Biology;Assembly of collagen fibrils and other multimeric structures;Signal Transduction;Collagen chain trimerization;Collagen biosynthesis and modifying enzymes;Integrin cell surface interactions;Collagen degradation;Signaling by PDGF;Collagen formation;Extracellular matrix organization;Integrin;Degradation of the extracellular matrix;NCAM signaling for neurite out-growth;NCAM1 interactions;Axon guidance;ECM proteoglycans;Signaling by Receptor Tyrosine Kinases (Consensus)

Intolerance Scores

loftool
0.0916
rvis_EVS
0.61
rvis_percentile_EVS
82.97

Haploinsufficiency Scores

pHI
0.498
hipred
N
hipred_score
0.413
ghis
0.446

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
E
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.808

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumHigh
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Col9a3
Phenotype

Gene ontology

Biological process
male gonad development;female gonad development;extracellular matrix organization
Cellular component
extracellular region;collagen type IX trimer;extracellular space;endoplasmic reticulum lumen;extracellular matrix
Molecular function
extracellular matrix structural constituent;extracellular matrix structural constituent conferring tensile strength